Global Microplate Systems Market 2026 – 2035

Reports Description

The market size of global microplate systems is estimated to be USD 1.42 billion in 2025 and it is expected to grow from USD 1.57 billion to USD 2.88 billion between 2026 and 2035 with a CAGR of 10.7% market growth is sponsored by the growing use of laboratory automation, the growing need for high-throughput screening in the drug discovery process, the increase in the number of applications in personalized medicine, and the growing popularity of chronic diseases in the world.

Market Highlight

• According to the market share, the microplate systems market clearly had North America as the leader with a 40% market share in 2025.

• Asia Pacific will have the highest CAGR of 12.3% between 2026 and 2035.

• Through product type, the microplate readers market segment took about 52% of the market share in 2025.

• Multi-mode microplate readers segment By product type, the multi-mode microplate readers segment is experiencing a healthy CAGR of 11.5% between 2026 and 2035.

• The drug discovery segment posted the highest market share of 38% in 2025 by application and the genomics and proteomics research segment is projected to grow with the quickest CAGR of 13.2% within the period between 2026 and 2035.

• By end-user, the segment of pharmaceutical and biotechnology companies took control of a market share of 45% in 2025.

Significant Growth Factors

The Microplate Systems Market Trends present significant growth opportunities due to several factors:

• Rising Demand for High-Throughput Screening and Laboratory Automation: The growing requirement to use high-throughput screening (HTS) in pharmaceutical and biotechnology drug discovery is a major motivator behind the sale of microplate systems, and the labs are in search of effective ways to screen thousands of compounds at once against particular biological targets. Data released by the National Library of Medicine in 2024 states that high throughput screening is regularly employed to detect bioactive small molecules and in drug discovery and development, it is a vital method, enabling the researcher to test compounds rapidly and effectively. The use of automated microplate systems in high-throughput screening has become a standard in more than three-quarters of the largest pharmaceutical companies and will greatly accelerate the discovery of lead compounds in early-stage drug discovery pipelines by 2025. Such fast assessment is critical in the determination of the potential drug candidates, faster process of research and lower drug research cost in comparison with the conventional tests. The necessity of microplate systems enhances the ability to handle many samples at a time, which could not be done without them in the world of modern laboratories that are centering on precision medicine and overall screening systems. Moreover, by combining robotic automation and liquid handling with microplate readers, throughput, accuracy, and reproducibility are improved, and the risk of manual errors and sample contamination is reduced. With pharmaceutical and biotechnology firms accelerating their drug development cycles and lowering their cost of doing business, the use of super microplate systems that are capable of automation will keep on propelling the massive market growth.

• Technological Advancements and Integration of AI-Powered Analytics: The movement of the microplate systems has expanded significantly in the market with the evolution in technology and implementation of artificial intelligence in laboratory equipment. Technologies in this field have seen the introduction of multi-mode microplate readers with hybrid optics, AI-based data analytics systems, novel detection methods, and cloud-based information management systems in laboratories to enable users to deliver better sensitivity, flexibility, and real-time decision-making. By 2025, more than 70% of pharmaceutical R&D laboratories will be utilizing AI-improved microplate readers to perform real-time assay analysis and decision-making, and studies in 2024 show up to a 40% cut in data interpretation time and enhanced experimental reproducibility with AI-integrated microplate systems. Desirable modern identifiers such as multimode detection (absorbance, fluorescence, luminescence, and time-resolved fluorescence) and temperature control systems, automated plate handling and integration into laboratory automation processes are now capabilities of modern microplate readers. As an example, in July 2025, Molecular Devices released the SpectraMax iD5e and iD3s Multi-Mode Microplate Readers which include tunable monochromator-based measurement capabilities, temperature control, dual injectors with SmartInject Technology, and gas mixers that can be installed by the user, allowing additional flexibility on assays and live-cell experimentation. In February 2023, PerkinElmer released the EnVision Nexus multimode plate reader, the quickest and most sensitive platform that the company has made, meant for rapid screening in high throughput with wide assay versatility to speed up drug discovery processes. Also, the ongoing product improvement of the major manufacturers is still a strong competitive edge combined with the development of product and consequently, the demand level in the marketplace rises, and the outcomes of the researchers working with complex biological assays, genomics research and applications of clinical diagnostics improve.

What are the Major Advances Changing the Microplate Systems Market Today

• Multi-Mode Detection and Hybrid Optical Systems: The multi-mode capability of the microplate reader systems to operate multi-mode detection and multi-mode hybrid optical systems in a single microplate reader offers researchers unparalleled versatility to perform a wide variety of assays without changing instruments. Multi-mode readers that can be used to measure absorbance, fluorescence intensity, luminescence, time-resolved fluorescence (TRF) and fluorescence polarization (FP) allow the simultaneous analysis of biological samples in a single workflow. These innovative systems can be applied widely in enzyme kinetics, protein quantification, cell viability testing and drug testing to name just a few, thus greatly enhancing the productivity of laboratory work and saving on equipment expenses. The advancement of the hybrid optical systems that incorporate the use of filters and monochromators enables researchers with the capability to maximize sensitivity and flexibility of wavelength in line with the requirements of the particular assays.

• Automation and Robotic Integration: The continuation of completely automated microplate handlers and robotic integration platforms has transformed the operations of the laboratory by facilitating walk-away automation of complex multi-step protocols. Automated microplate dispensers, washers and stackers can be easily integrated with microplate readers to form entire liquid handlers, which decrease human intervention, error, and throughput. High throughput screening MPA Microplate automation is predicted to increase by 25% in 2025 as the market recognizes the need to get faster drug candidate testing and is under pressure to process more samples with higher consistency and reproducibility.

• Artificial Intelligence and Cloud-Based Data Management: With the introduction of AI-based analytics and machine learning algorithms embedded in the software of a microplate reader, it is possible to process data intelligently, detect anomalies, and predict possible models. Embedded analytics based on artificial intelligence to process data in real time and detect anomalies will become available on more than 60% of new microplate readers by 2025. Integration of cloud-based laboratory information management systems (LIMS) enables researchers to access, maintain and distribute large datasets across various locations which enables collaborative research and ensures data integrity. New and sophisticated software platforms provide automated curve fitting, quality control and statistical analysis functions that make data interpretation easier and save time in manual processing.

• Miniaturization and High-Density Formats: The introduction of microplate formats of ultra-high density, such as 384-well and 1536-well plates, allows laboratories to screen in large scale parallel screening campaigns whilst saving valuable reagents and biological samples. Later in 2024, 1536-well ultra-high-throughput microplates were introduced enabling laboratories to perform more than 10,000 simultaneous assays, which would make drug discovery programs much faster. The high-density formats are specifically useful in primary screening, compound library characterization and large scale genomics studies where both sample and reagent conservation are key considerations. Sophisticated detection optics and sensitive photomultiplier tubes allow the reliable detection of the signal even in small volumes of the wells.

Category Wise Insights

By Product Type

Why Microplate Readers Lead the Microplate Systems Market?

Microplate readers will also form the largest segment of the microplate systems market in 2025 with a market share of around 52. This supremacy is attributed to the critical functions that these tools are involved in, identifying and measuring biological, chemical, and physical reactions in many laboratory uses. Enzyme-linked immunosorbent assays (ELISA), cell viability, protein and nucleic acid quantification, drug screening campaigns, and thousands of other different experimental procedures rely on microplate readers as their analytical foundation. The wide application of these tools guarantees their use in pharmaceutical research, clinical diagnostics, biotechnology development, and academic research, where quantitative measurement features are the leading requirements.

In the microplate readers, multi-mode readers are also showing strong growth owing to their capacity to conduct multiple detection techniques in one platform. Multi-mode microplate readers appear to be very versatile because they can be used with absorbance, fluorescence intensity, luminescence, time-resolved fluorescence, and fluorescence polarization detection modes, avoiding investments in multiple special instruments by the laboratory. As per market trends, in terms of research and drug discovery, multi-mode readers are favored because of their flexibility, and they are increasing at a CAGR of 11.5% between 2026 and 2035. These high-end systems allow scientists to perform high-end experimental processes, from simple biochemical screening to elaborate screening initiatives using a single instrument platform. Additional functionalities like temperature control, reagent loading systems, dual systems of reagent injection and advanced data analysis software have added further interest in multi-mode readers to the research laboratories that want to enjoy their maximum analytical capacity with minimal equipment cost and laboratory bench space.

Single-mode microplate readers are still used in niche applications that demand specific performance in a particular detection mode. Absorbance readers are still used as the workhorse in situations such as ELISA, protein quantification with colorimetric assays, and monitoring bacterial growth. Fluorescence readers have a better sensitivity when high sensitivity is needed in the application where a low level of analyte has to be detected and the luminescence readers have the highest sensitivity in case the reporter gene assays and ATP quantification experiments are required. Most high-throughput screening systems have special single-mode readers to use in special applications when it is important to get the best performance in a single detection mode at the expense of multi-modal capability.

The microplate washers sector plays a very important role in the market ecosystem, especially for the laboratories that deal with immunoassay based research and clinical diagnostics. Microplate washers are essential in ELISA protocol and other methods that involve repetitive steps of washing to remove the unbound reagents and minimize the background signal. These automated washing systems increase the assay consistency, increase reproducibility and decrease manual labor by a large margin compared with manual washing procedures. Contemporary microplate washers offer programmable wash parameters, multiple dispensing, and aspiration options, as well as compatibility with automation systems in the laboratory.

Pipetting systems and microplate dispensers constitute an emerging market due to the growing automation in laboratories and the requirement of handling liquids with great accuracy during high-throughput usage. The systems provide reproducible and precise reagent addition to all wells of microplate formats from 96-well to 1536-well formats. Advanced models have peristaltic pumps, solenoid valves or positive displacement pumps that produce constant volumes despite hard liquids like viscous solutions, suspension, and cell- or particle-containing media. Complex plate layouts and high-level experimental designs can be designed and implemented effectively by using the integration of random access dispensing (RAD) and parallel dispensing technologies in a laboratory.

By Application

Why Drug Discovery Dominates the Microplate Systems Market?

The largest market of the microplate systems is drug discovery applications, which will contribute around 38% of the total market share in 2025. The importance of microplate-based assays in the entire drug development pipeline, including the initial target identification and validation to the final hit-to-lead optimization and preclinical candidate profiling, is demonstrated by this leadership role. Microplate systems are of great importance in pharmaceutical and biotechnology firms to carry out high-throughput screening campaigns assessing hundreds of thousands to millions of chemical compounds against a given biological target(s). Industry analysis revealed that a major pharmaceutical company that installed multi-mode microplate readers into the drug screening pipeline was getting a 30% throughput increase and a 25% cut in reagents expenses, which clearly indicates how effective such systems are with regard to their operation.

Drug discovery process requires a microplate system, which can perform various assay type such as biochemical enzyme assays, cell-based phenotypic screens, receptor binding assays, ion channel assays, and cytotoxicity assays. Recent drug discovery efforts are now more physiologically relevant by using three-dimensional cell culture models, patient derived organoids and multicellular co-culture models that are more likely to predict in vivo efficacy and safety phenotypes. The latest microplate readers with environmental control such as temperature adjustment, CO₂ and O₂ regulation, and humidity control allow long-term live-cell monitoring experiments which give kinetic data on the influence of compounds on the cellular processes. Automated liquid handling, compound management systems and advanced data analysis platforms come together to form whole drug screening ecosystems that are as efficient as possible and as data rich as possible.

The trend toward precision medicine and targeted therapies has added to the acuity of the need to use microplate systems in drug development. Screenings are currently being performed in various disease-relevant cell lines, patient-derived samples and genetically diverse populations to select compounds with the most favorable therapeutic indices and reduced off-target effects. Multi-parametric datasets of viability, apoptosis markers, and pathway activation status and phenotypic readouts made possible by modern microplate systems allow a complete characterization of compounds guiding medicinal ways of optimization and minimizing downstream attrition rates.

Clinical diagnostics segment is a large and expanding microplate system application field due to the rising demands of laboratory test services in the global market. Microplate-based infectious disease serology, autoimmune disorder screening, hormone level assays, tumor marker assays, and therapeutic drug monitoring are clinical diagnostic lab tests. These platforms are considered the gold standard of innumerable clinical tests due to the standardization and regulatory acceptance of microplate-based ELISA and chemiluminescence immunoassays. The market reports indicate that a diagnostic laboratory in Europe that converted to an AI-powered microplate system recorded a 4-hour test turnaround time, which is lower than 8 hours, indicating the effect of technological improvement on the efficiency of the clinical laboratory and the delivery of services to patients.

Genomics and proteomics research division has the highest growth rate in the microplate systems market and is set to grow at a rate of 13.2 between the years 2026 and 2035. Such fast growth indicates the high-pressure growth of next-generation sequencing applications, CRISPR-based genetic screening, technologies of single-cell analysis, and large-scale research on protein expression profiling. The microplate systems allow scientists to perform library preparation, quality control measurements, and quantification steps necessary during genomics processes. Microplate readers are used in the proteomics studies to carry out studies on protein-protein interactions, post-translational modifications, and antibody validation. The broader use of mass cytometry, spatial transcriptomics, and other emerging omics tools generates a long-term need to support more complicated sample acquisition and analytical methods of current molecular biology studies with microplate-based systems.

By End-User

Why Pharmaceutical and Biotechnology Companies Lead Microplate Systems Adoption?

The pharmaceutical and biotechnology companies constitute the largest end-user market in the market of microplate systems as they were estimated to contribute to about 45% of market share in 2025. The dominance is based on the leading role of these instruments in the research of drug discovery, biologics development, the production of vaccines, and the quality control processes of life sciences companies. Pharmaceutical and large research companies have large-scale compound screening laboratories, which use lots of microplate reader platforms, automated liquid handlers, and automated lab automation systems with the capacity to test millions of compounds each year. The large amounts of R&D money invested by the pharmaceutical companies—in 2024, approximately USD 18 billion of investment in new laboratory facilities has been recorded in North America, Europe, and Asia-Pacific—create the ceaseless demand for the state-of-the-art microplate systems with the improved capabilities.

Biotechnology firms, large biologics manufacturing organizations, and new cell therapy developers are highly dependent on microplate systems as the main mode of process development, quality assurance testing, and research purposes. Microplate-based assays are also used in biopharmaceutical production plants to measure cell culture parameters, product titers, product quality parameters, and stability testing. The growth of biologics development, such as monoclonal antibodies, recombinant proteins, cell therapies, and gene therapies, generates a continuous pressure on microplate systems that can be used to execute specialized assays that are specific to the modalities. Another important user group is contract research organizations (CROs), which offer drug discovery and development services to pharmaceutical and biotechnology customers and in which these service providers invest heavily in multi-purpose microplate systems capable of supporting various client projects and assay types.

The segment of the final users that is significant comprises hospital and diagnostic laboratories owing to the necessity of the use of microplate-based immunoassays in clinical chemistry, microbiology, and specialty testing departments. Microplate readers in hospitals are used in routine diagnostic tests such as infectious disease serology, autoimmune disorder tests, hormone and tumor marker assays. High-quality microplate-based clinical assays and regulatory approval of many diagnostic tests using microplate technology with 96-well plates guarantee the further use of these technologies in the clinical environment. High-volume diagnostic reference labs serving large numbers of samples submitted by various medical professionals use automated microplate systems with laboratory information systems in place to produce effective sample throughput and quality test results. The rising number of chronic diseases that demand constant monitoring in laboratories and the aging population of developed nations justifies stable clinical diagnostic implementation of microplate technology.

Academic research and academia is a large and expanding end-user market, including research laboratories of universities, government research labs, and non-profit research institutes. Microplate systems are used by academic researchers in the basis of biological research, disease mechanism research, and preclinical studies of therapeutic targets. The purchases of equipment are motivated by the availability of research grants and government funds for the study of life sciences, specifically in such fields as cancer biology, neuroscience, infectious diseases, and regenerative medicine. Most universities have core facility facilities (stocked with shared instrumentation), such as state-of-the-art microplate readers that share use between research groups, maximizing the utilization of instruments and allowing researchers with small individual budgets to access a wide range of advanced analytical facilities. Training of future scientists on industry-standard microplate platforms in the academic environment also helps in the long-term demand and acquaintance with these fundamental laboratory instruments.

Report Scope

Regional Analysis

How Big is the North America Microplate Systems Market Size?

The North America microplate systems market size is estimated at USD 568 million in 2025 and is projected to reach approximately USD 1,144 million by 2035, with a 10.2% CAGR from 2026 to 2035.

Why did North America Dominate the Microplate Systems Market in 2025?

The largest participant in the global market of microplate systems is North America, which is expected to dominate the market (estimated to control about 40% of the market in 2025) owing to well-developed pharmaceutical and biotechnology sectors, massive investment in research and development, well-developed healthcare infrastructure, and good reimbursement policy on diagnostic testing. The North American region is the first in the use of the laboratory automation technologies, and the United States makes the largest contribution as to the total market revenue. The dominance of North America in leadership in the pharmaceutical industry is due to the concentration of the large pharmaceutical companies such as Pfizer, Johnson & Johnson, Merck and several biotechnological firms with large drug discovery programs. Moreover, the availability of the major manufacturers of microplate systems, such as Thermo Fisher Scientific, Agilent Technologies, PerkinElmer and Molecular Devices is a guarantee of timely access to the latest technological inventions by North American laboratories.

What is the Size of the U.S. Microplate Systems Market?

The U.S. microplate systems market size is estimated to be USD 490 million in 2025 and almost USD 980 million in 2035 with a high CAGR of 10.0% between 2026 and 2035.

U.S. Microplate Systems Market Trends

The US microplate system market is the largest segment of the global market due to the high pharmaceutical research and development activities, the high level of research funding offered by government agencies such as the National Institutes of Health (NIH), and the continuous technological improvement of multi-mode readers, artificial intelligence (AI) analytics, and automation systems in the laboratories. The high level of public and private financing of life sciences research, the ageing population that requires more diagnostic tests, and the transition towards personalized medicine provide significant opportunities to develop the market. Investments in new laboratory infrastructure are projected to reach USD 18 billion in North America in 2024, and more than 40% of this will be in automated microplate systems, showing how much capital is being invested in improving laboratory capacity.

Why is Asia Pacific Experiencing the Fastest Growth in the Microplate Systems Market?

The Asia-Pacific region is expected to be the most successful in terms of the microplate systems market, and the CAGR is estimated at 12.3% between 2026 and 2035. The high growth rate is indicative of the growing investments in pharmaceutical R&D, the efforts of the government to improve the health care infrastructure, the rising number of chronic diseases that require diagnostic testing, and an increased awareness of the advantages of laboratory automation. With the large population of people in the Asia-Pacific region, including China, India and Japan among others, the need to still enhance economic development and modernization of healthcare facilities generates huge demand of the microplate systems in pharmaceutical companies and diagnostic labs as well as in academic research centers. The potential growth opportunity in Asia-Pacific markets has been shown by the fact that annual demand of microplates is projected to exceed 50,000 units in 2025.

China Microplate Systems Market Trends

The Chinese market has a large and fast developing microplate systems market due to intense government investment in biotechnology advancement, proliferation of local pharmaceutical and biotechnology enterprises, clinical diagnostic infrastructure development, and the rising use of laboratory automation systems. Strategic efforts by the Chinese government to improve national drug discovery and decrease reliance on imported therapeutics and treatment methods have helped in boosting investments in research facilities that have current state-of-the-art instrumentation such as microplate systems. Also, the growing middle class that gains access to healthcare services and the rise in chronic diseases like diabetes, cardiovascular conditions, and cancer are all factors that are driving the demand in both research and diagnostic applications of microplate technology.

Why is Europe Entering a New Era of Microplate Systems Market?

The European market to microplate systems is large, as it represents the robustness of the pharmaceutical industry, the developed biotechnology sector, developed healthcare systems, and rich academic research infrastructure. Europe has a large portion of the entire market, with the large pharmaceutical firms of Novartis, Roche, Sanofi, and AstraZeneca carrying out a lot of research on drug discovery relying on microplate-based screening technologies. The focus on technology in the region towards precision medicine, customized therapeutics, and new diagnostic methods promotes further acquisition of the new microplate systems that have multi-mode detection and automated features.

Germany Microplate Systems Market Trends

In Europe, Germany has one of the highest markets of microplate systems because the country has a highly developed pharmaceutical industry with a great number of biotechnology companies, a rich clinical diagnostic network and positive academic research conditions. German research facilities and pharmaceutical firms are the early users of new technologies, which has created a need to have the latest microplate readers with Artificial Intelligence, new detection modes, and automatic processes. The manufacturing excellence and quality control that the country has been focusing on is also projected on the purchasing of laboratory instrumentation with German laboratories highly preferring high-performance systems of well-known manufacturers.

Why is the Middle East & Africa Region Accelerating Adoption of Microplate Systems?

The market of the microplate systems in the LAMEA region is facing growth stability, and the development of the market is not even in all countries and indicates different levels of healthcare infrastructure and economic conditions. The Middle East area, and especially the Gulf Cooperation Council (GCC) countries such as Saudi Arabia and the United Arab Emirates, is showing a growing interest in healthcare modernisation, the creation of research facilities, and the creation of biotechnology industries. Such investments also include the purchase of better laboratory facilities such as microplate systems to facilitate the increasing pharmaceutical research work and increasing diagnostic testing capacities. The nascent market development in Africa is more evident but the rising awareness of the benefits of automation in the laboratory and the slowing of the infrastructure in the medical sector indicate future growth potential.

Brazil Microplate Systems Market Trends

The development of the microplate systems market in Brazil is motivated by the increase in the size of the private healthcare industry, the growth in the pharmaceutical R&D activities by both the local and multinational firms, and the increase in the demand of the clinical diagnostic services. There is an increase in the trend of Brazilian pharmaceutical firms and research centers implementing automated lab methods to increase research output and diagnostic levels. Since Brazilian access to healthcare is steadily growing, and modern methods of diagnostics are increasingly being recognized, the future of the adoption of microplate systems is bright, but short-term market trends may be influenced by financial instability and the limitations of the healthcare budget.

Top Players in the Microplate Systems Market and Their Offerings

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Tecan Group Ltd.
• BMG LABTECH GmbH
• Molecular Devices LLC
• Promega Corporation
• Corning Incorporated
• Others

Key Developments

The Microplate Systems Market has experienced major trends in the recent two years with industry players aiming to increase geographic reach, develop product lines and consolidate competitive activities by undertaking strategic change initiatives.

• In July 2025: Molecular Devices released the SpectraMax iD5e and iD3s Multi-Mode Microplate Readers. The following generation systems are characterized by tunable monochromator based measurements, advanced temperature control, dual injectors with SmartInject Technology, and user installable gas mixers that offer greater flexibility to the researcher in allowing a wide range of assays and live-cell analysis applications. The readers celebrate 40 years of trustworthiness and integrate new technologies to satisfy the changes in the requirements of the contemporary laboratories that engage in high-end multi-omics studies. (Source: https://www.moleculardevices.com/)

• In February 2023: PerkinElmer Inc. developed the EnVision Nexus multimode plate reader, the first and, to date, fastest and most sensitive platform obtained by the company. The system is indeed tailored with the idea of expediting the drug discovery processes and facilitating high-throughput screening applications where a wide assay range is required. The EnVision Nexus is the combination of the patented HTRF and AlphaLISA technologies of PerkinElmer in addition to reagents and microplates optimized to provide a higher performance and reproducibility of the assays. (Source: https://www.perkinelmer.com/)

These strategic product releases and technological advancements have enabled businesses to reinforce their marketplace standing, meet the new customer demands in line with the higher performance and versatility, and exploit growth prospects of the growing Microplate Systems Market.

The Microplate Systems Market is segmented as follows:

By Product Type

• Microplate Readers
  • Single-Mode Microplate Readers
    • Absorbance Microplate Readers
    • Fluorescence Microplate Readers
    • Luminescence Microplate Readers
  • Multi-Mode Microplate Readers
    • Filter-Based Microplate Readers
    • Monochromator-Based Microplate Readers
    • Hybrid Microplate Readers
• Microplate Washers
• Microplate Dispensers and Pipetting Systems
• Microplate Handlers
• Microplate Accessories and Software

By Application

• Drug Discovery
• Clinical Diagnostics
• Genomics and Proteomics Research
• Other Applications
  • Environmental Testing
  • Food Safety Analysis
  • Agricultural Research

By End-User

• Pharmaceutical and Biotechnology Companies
• Hospital and Diagnostic Laboratories
• Research and Academic Institutes
• Contract Research Organizations (CROs)

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America